Quick ReadPlain-language overview · read this first
Chubb is a global P&C insurance group operating in 54 countries, with roughly 60% commercial insurance and 40% consumer insurance. Underwriting, investment income, and life insurance all contribute to profits. Rating: Watch; a good company at a reasonable price, but far from meaningfully undervalued.
The real moat is underwriting discipline. Over the past four years, the combined ratio has stayed in a tight 87.6% to 85.7% range. In 2025, despite pretax catastrophe losses reaching USD 2.92 billion, the full-year ratio still set a record at 85.7%; in 2026Q1, it improved further to 84.0%. On the capital side, shareholders' equity was USD 73.788 billion, financial debt/adjusted capitalization was only 18.3%, and major entities were rated Aa2/AA/A++. Greenberg has served as CEO since 2004, the dividend has been raised for 33 consecutive years, and incentives are tied to tangible book value and the combined ratio. Capital allocation is long-term oriented, but not price absolutist: from 2024 through 2026Q1, the company was still repurchasing shares as the average buyback price rose from USD 269 to USD 325.
But current earnings are enjoying a cyclical tailwind. Catastrophe losses were USD 1.641 billion in 2025Q1 and only USD 500 million in 2026Q1, so the strong quarter partly reflects a base effect. Conservative Owner Earnings are USD 19.5–20.5 per share, implying 16–17 times earnings rather than the superficially cheap low-11-times multiple. The analyst's fair value range is USD 300–345, with an ideal buy zone of USD 260–290; the current USD 328.25 price is close to the fair value midpoint. The biggest threat is permanent capital loss: casualty reserves deteriorating, pricing softening, and valuation resetting from 1.7 times to 1.1–1.2 times BVPS could imply a potential 30%–45% drawdown. At the current price, the conservative-case annualized return is only 4%–6%. This is a company worth respecting, but not worth chasing.
LeadA high-quality global P&C insurance group. Chubb combines disciplined underwriting, rising investment income, and a diversified global franchise, with a full-year 2025 combined ratio of 85.7% and Q1 2026 at 84.0%. Rating Watch: at $328.25, the stock sits near the midpoint of a fair value range of $300-345, while earnings are near a cyclical high and the margin of safety is not obvious; the ideal buy range is $260-290.
Prices in the article are as of publication; see the valuation band above for the live price.
Conclusion First
Here is the judgment in one paragraph: the investment rating is Watch, and the current margin of safety is not obvious. The core view is that Chubb is a high-quality, global insurance group with strong underwriting discipline, and the business deserves long-term tracking; however, at the current share price of roughly $328.25, it looks more like a "good company at a fair price" than a clearly undervalued opportunity. The right investor profile is a long-term value investor who understands insurance accounting and reserves, is willing to hold for years, and prioritizes quality over maximum statistical cheapness. The largest uncertainties are mainly three: whether commercial/casualty reserves reverse, catastrophe losses and reinsurance costs, and whether the industry pricing cycle weakens materially over the next two to three years.
My preliminary conclusion is: Chubb's "business quality" is higher than that of most insurers, but its "investment odds" are not as exceptional as its business quality. Based on the latest available market data, CB trades at about $328.25; the company generated $10.31 billion in net income and $9.954 billion in core operating income in 2025, and at the end of Q1 2026 had $73.788 billion in Chubb shareholders' equity, $95.294 billion in total adjusted capitalization, and a financial debt-to-adjusted capitalization ratio of 18.3%. In terms of business physique, it almost fits the textbook definition of a high-quality insurer; in terms of price, I would rather treat it as a core watchlist name among excellent businesses, not the fat pitch that must be swung at today.
If the question is "is this a business worth owning for the long term," my answer is yes; if the question is "has today's price already given conservative investors enough margin of safety," my answer is not enough. Chubb's strength is that it combines underwriting profit, investment income, and global distribution; but current earnings also sit in a relatively favorable phase: in 2025 the company recorded its lowest full-year P&C combined ratio in history at 85.7%, and in Q1 2026 its combined ratio was 84.0%, which means any purchase must respect the possibility of "earnings mean reversion."
Business Understanding and Industry Structure
How This Company Actually Makes Money
Chubb is a global insurance and reinsurance group operating in 54 countries and territories, providing commercial property insurance, casualty insurance, personal P&C, accident and supplemental health insurance, reinsurance, and life insurance to corporate clients, individual clients, and other insurers. Based on its Q1 2026 reporting framework, its segments include: North America Commercial P&C, North America Personal P&C, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. In the 2025 shareholder letter, management described the company as broadly 60% commercial insurance and 40% consumer insurance.
Its revenue essentially comes from three layers: the first layer is underwriting income, meaning underwriting profit after deducting claims and expenses from premiums; the second layer is investment income, meaning returns earned by investing insurance float and shareholder capital into fixed income, private equity, real-estate-related assets, and other investments; the third layer is fee income and long-term policy value creation from life insurance and international consumer businesses. In 2025, the company generated $6.528 billion in P&C underwriting income, $6.47 billion in pre-tax net investment income, and $1.242 billion in life insurance segment income; all three legs were profitable and all reached relatively high levels in the company's history.
The customer base is highly diversified. Management describes its customers as spanning large multinational corporations, small and midsize enterprises, high-net-worth individuals, and middle-income families; the reinsurance business serves various primary insurers. In other words, this is not a business dependent on a single large customer. It depends more on broker and agent networks, brand reputation, claims reputation, rating-agency recognition, underwriting technology, global licenses, and localized operations. These things are hard to fully quantify in financial statements, but for an insurer they are the true "intangible assets" that determine renewal rates and pricing power.
In terms of revenue recurrence, insurance has more of a "renewal" characteristic than industrial products or discretionary consumption. Most policies are repriced annually or on even shorter cycles, which means revenue is less locked in than subscription software but much steadier than one-off engineering projects. For Chubb, the mix of commercial insurance, personal insurance, and life insurance reduces single-line volatility; in Q1 2026, the company's total net premiums were $14.005 billion, up 10.7% year over year, including P&C at $11.716 billion, up 7.2% year over year, and life insurance at $2.289 billion, up 33.1% year over year, showing that it still has organic growth capacity.
The most important parts of the cost structure are loss costs, acquisition costs, and administrative expenses, not factories, equipment, and raw materials. For an insurer, the most important operating metric is the combined ratio. Chubb's full-year combined ratios over the past four years were 87.6%, 86.5%, 86.6%, and 85.7%, consistently below 90%, showing that it is not merely "selling policies," but selling policies with underwriting profit. Many insurers "lose money on underwriting and rely on investments to make up the difference"; in recent years, Chubb has not been that kind of insurer.
I give this business 4/5. It is easier to understand than a bank and more diversified than a pure-play reinsurer; however, it still involves accounting and risk complexity such as reserve estimates, catastrophe models, reinsurance structure, and AOCI volatility, so I would not give it a perfect score. If the stock market closed for 5 years, I would be willing to hold it from a business perspective; but from today's price perspective, I would be more selective.
Industry and Competitive Landscape
Insurance is not a "naturally perfect" industry. It has three characteristics: stable long-term demand, cyclical short-term profitability, and extreme dependence on discipline. NAIC's 2025 midyear report showed that U.S. P&C industry direct premiums written grew 6.1% year over year in the first half of 2025, below 10.5% in the same period of the prior year; the report attributed part of the slowdown to underwriting improvement, capital recovery, and stronger competition. Swiss Re also judged that non-life industry profitability would remain strong in 2025-2026, but underlying U.S. P&C profitability would begin to be eroded by higher underwriting capacity and renewed competition. In other words: demand is stable, but pricing and margins do not move up in a straight line.
By overall market share, Chubb is not an "absolute oligopoly" in U.S. P&C. Insurance Information Institute data show that by 2024 U.S. P&C direct premiums written, Chubb ranked No. 8, with direct premiums written of about $32.29 billion and a market share of 3.1%. This precisely shows that its strength is not mass-market standardized products, but commercial insurance, complex risks, high-net-worth personal insurance, global multi-region operations, and a high-quality customer base. It is more like a "leader in high-value-added niches" than "the largest mass-market auto insurer."
Among the main comparables, Travelers is closer as a U.S. commercial P&C comparable, Progressive is an outstanding peer with very strong personal-lines pricing capability, and Arch Capital is another type of high-quality insurance institution with strong capital allocation and underwriting discipline. Compared with these companies, Chubb's distinctiveness lies in: a more balanced international footprint, deeper commercial-insurance capabilities, a larger high-net-worth personal-lines franchise, and rapidly growing international life/consumer businesses. That makes it more of a "multi-engine insurance holding company" within the industry.
Therefore, I give this industry 3.5/5. It is not a naturally exceptional industry like Coca-Cola's category; but within a "medium-quality industry," Chubb is one of the few high-quality companies that genuinely deserves long-term comparison. My one-sentence summary is: not an absolutely perfect company in a great industry, but a first-class company in a medium-quality industry.
Moat
Chubb's moat is not single-source; it is a "compound barrier" formed by several moats layered together.
| Moat Element | Judgment | Evidence and Explanation |
|---|---|---|
| Brand advantage | Yes | In commercial insurance, high-net-worth personal insurance, complex claims, and cross-border service, brand and claims reputation matter greatly; Chubb emphasizes its broad product set and claims-service capabilities. |
| Cost advantage | Moderate | It has advantages in scaled claims handling, reinsurance purchasing, data accumulation, and shared global back office functions, but insurance is not a classic lowest-cost-winner-takes-all industry. |
| Scale advantage | Strong | 54 countries and territories, broad distribution, a $170.195 billion investment portfolio, and $73.788 billion in shareholders' equity. |
| Network effects | Weak | It does not have software-platform-style network effects. |
| Switching costs | Moderate | Commercial clients, brokers, and multinational program policies have relationship stickiness, while ratings and claims history raise switching costs. |
| Channel advantage | Strong | Global broker channels, local branches, and direct/digital partner capabilities in Asia create distribution barriers. |
| Licensing and regulatory barriers | Strong | Multi-jurisdiction licenses, regulatory capital requirements, and high rating thresholds are not easy to replicate. |
| Data advantage | Moderately strong | Large volumes of historical claims and risk data help pricing and risk selection, but this is not an unassailable data monopoly. |
| Corporate culture and operating capability | Strong | Long-term underwriting discipline is reflected in combined ratios consistently below 90%. |
| Capital allocation capability | Fairly strong | Repurchases, dividends, acquisitions, and portfolio management have generally been rational, although whether repurchases at the current price are "cheap" is not always obvious. |
Note: the moat judgment is based on the company's business and geographic footprint, the commercial/consumer mix and international distribution information in the 2025 shareholder letter, the Q1 2026 balance sheet and investment portfolio scale, the 2026 ratings summary, and the consistently strong combined-ratio record from 2022 to 2025.
I think Chubb's moat is stable to slightly widening. Stability comes from the brand, ratings, and claims-service barriers in traditional commercial insurance and high-net-worth personal insurance; slight widening comes from expansion in international consumer businesses, digital partners, life insurance, and Asia. For competitors to replicate this combination, they would need many years, tens of billions of dollars in capital, multinational licenses, reinsurance and broker-channel relationships, and a very long underwriting history. This cannot be copied in one or two years.
In an inflationary environment, the biggest benefit for insurers is that they can reprice. Chubb has continued to grow across most commercial and personal lines in recent quarters; however, in Q1 2026, North America major accounts property was a drag on part of overall growth because of reduced exposure and lower rates, showing that it does not have unconditional pricing power, but rather chooses business with discipline. In other words, it can raise prices, but it will not sacrifice returns for premium volume. That is exactly the hallmark of a good insurer.
In an economic downturn, Chubb also has a better chance of remaining profitable: from 2022 to 2025, despite FX fluctuations, catastrophe years, and capital-market disruption, the company's full-year P&C combined ratio stayed in the 87.6% to 85.7% range, while core operating income rose from $6.457 billion to $9.954 billion. Still, insurance earnings are affected by catastrophes and casualty reserves, so stability does not mean linearity.
I give the moat strength 4/5. It is not a network-effect moat, but in the insurance industry it is already a rare "deep and broad" combination of barriers.
Management and Capital Allocation
Evan Greenberg has served as CEO since 2004 and chairman since 2007; under his tenure, ACE acquired Chubb in 2016 for $28.3 billion, creating today's platform. Judging solely by the outcome, this large acquisition did not push the company into uncontrolled expansion; instead, it turned the platform into a more complete global insurance complex. The Cigna Asia life/health business that was integrated in 2022 also made life insurance a more meaningful third profit source: Chubb's life insurance net premiums rose from $3.64 billion in 2022 to $7.279 billion in 2025, and segment income rose from $1.098 billion in 2024 to $1.242 billion in 2025. At minimum, these facts show that large acquisitions have so far enhanced platform quality rather than destroyed discipline.
In management incentive design, the point I like most is this: the company's Q1 2026 10-Q disclosed that key metrics for performance shares/performance units include growth in tangible book value per share and P&C combined ratio relative to peers. That is far better than simply looking at revenue growth or polished EPS, and it is closer to what business owners care about. At the same time, proxy materials show that the company has governance rules such as mandatory executive share-ownership guidelines, a prohibition on hedging Chubb securities, and a prohibition on new pledges of Chubb stock by executives and directors. For an insurer, these are not decoration; they are external expressions of discipline.
On capital allocation, Chubb is very balanced. It continues to pay dividends, and the board recommended in 2026, later approved by shareholders, the 33rd consecutive annual dividend increase, raising the annualized dividend from $3.88 to $4.08. Meanwhile, the company continues to repurchase shares at large scale: in full-year 2024 it repurchased $2.02 billion at an average price of $269.23; in the first three quarters of 2025 it repurchased $2.29 billion at an average price of $282.38; and in Q1 2026 it repurchased another $1.14 billion at an average price of $325.06. This shows that management continues to put "per-share value" ahead of "absolute size."
But I also need to point out the imperfect side: repurchases do not always happen when the stock is "clearly cheap." From $269 to $282 to $325, the company kept buying, which indicates that management believes the shares have long-term value; for outside shareholders, however, that does not automatically mean "today is very cheap." So my assessment of capital allocation is: rational, long-term oriented, better than most peers, but not price absolutist.
I give management and capital allocation 4.5/5. This is one of Chubb's important strengths.
Financial Quality and Owner Earnings
Financial Quality Checkup
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Consolidated net premiums written | $37.868 billion | $41.755 billion | $47.361 billion | $51.468 billion | $54.842 billion |
| Net income | $8.539 billion | $5.313 billion | $9.028 billion | $9.272 billion | $10.310 billion |
| Core operating income | $5.569 billion | $6.457 billion | $9.337 billion* | $9.197 billion | $9.954 billion |
| P&C underwriting income | $3.696 billion | $4.555 billion | $5.460 billion | $5.850 billion | $6.528 billion |
| P&C combined ratio | 89.1% | 87.6% | 86.5% | 86.6% | 85.7% |
| Operating cash flow | Not shown in this table | $11.24 billion | $12.63 billion | $16.18 billion | $12.82 billion |
| Adjusted operating cash flow | Unknown | Unknown | $12.18 billion | $15.90 billion | $13.91 billion |
Note: 2021-2025 premiums, net income, core operating income, underwriting income, and combined ratios come from the official Q4/full-year results releases for each year; for operating cash flow, 2022, 2023, 2024, and 2025 come respectively from the official full-year 2022, full-year 2023, full-year 2024, and full-year 2025 results releases. *2023 core operating income was affected by a one-time deferred tax benefit from Bermuda tax law, so the comparable basis should be viewed more conservatively.
From the trend, Chubb's premium scale compounded at close to 9.7% from 2021 to 2025, while underwriting income and core operating income grew faster, showing that the company is not "getting larger but thinner," but getting larger while underwriting discipline strengthens. Particularly noteworthy is that in 2025, despite catastrophe losses rising to $2.92 billion pre-tax, the full-year combined ratio still reached 85.7%; luck cannot explain that over the long run.
At the end of Q1 2026, the company had $275.456 billion in total assets, $170.195 billion in investment assets, $88.915 billion in unpaid claims reserves, and $73.788 billion in Chubb shareholders' equity; total financial debt was $17.470 billion, and the financial debt-to-adjusted capitalization ratio was 18.3%. In the fixed-income portfolio, based on S&P ratings, about 85% was BBB or above, showing that investment-asset quality is quite sound. Ratings summaries show that its main insurance entities are generally in the Aa2 / AA / A++ range, which is critical for customer acquisition, broker channels, and bidding on large projects.
Traditional industrial metrics such as ROIC, EV/EBITDA, net debt/EBITDA, and interest coverage are not very useful for insurers, because insurance liabilities themselves are part of the operating raw material. More useful metrics for Chubb are ROE, core ROE, core ROTE, combined ratio, debt-to-adjusted capitalization ratio, and fixed-income portfolio quality. According to company disclosures, 2025 ROE was 15.0%, core ROE was 13.7%, and core ROTE was 20.5%; in Q1 2026, the estimated pre-tax loss from a 1-in-100 U.S. hurricane was $3.823 billion, equivalent to only 5.2% of shareholders' equity, showing that while risk exposure exists, the capital buffer is not fragile.
"Are earnings real cash earnings?" For insurance stocks, this must be answered carefully. In 2024 and 2025, Chubb's adjusted operating cash flow was $15.9 billion and $13.91 billion, respectively, both above net income in the same periods; this indicates that accounting profit is not hollow. But I would not treat all of it as freely distributable free cash flow, because insurance operating cash flow includes growth in float and changes in working capital/reserves, which cannot be used for shareholder cash-distribution valuation in the same direct way as manufacturing free cash flow. Conclusion: earnings are supported by cash, but CFO cannot be mechanically treated as fully distributable profit.
On accounting risk, I do not see obvious aggressive red flags; instead, over the past few years the company has continued to record meaningful favorable prior-period reserve development: $856 million in 2024, $1.13 billion in 2025, and $286 million in Q1 2026. This usually looks more like evidence that historical reserves were conservative, not that future profits are being pulled forward. But there is also a reverse reminder here: if this metric turns from consistently favorable to consistently adverse over the next few quarters, the market will be highly sensitive.
Owner Earnings Estimate
For an insurer, I would not directly copy the manufacturing-company Owner Earnings formula. A more practical approach is: start with core operating income as the "clean earnings starting point," then deduct small maintenance capex for systems/operations and the capital that must be retained to maintain ratings and support premium growth. This is closer to the "earnings truly distributable to business owners" than directly using net income or CFO.
| Item | Nature | Amount |
|---|---|---|
| 2025 net income | Fact | $10.310 billion |
| 2025 core operating income | Fact | $9.954 billion |
| Maintenance capex/technology investment buffer | Assumption | About $500 million to $700 million |
| Capital retention to support ratings and premium growth | Assumption | About $1.5 billion to $1.8 billion |
| Conservative Owner Earnings | Inference | About $7.7 billion to $8.0 billion |
| Corresponding Owner Earnings per share | Inference | About $19.5 to $20.5 |
| Multiple implied by current price | Inference | About 16x to 17x |
Note: 2025 net income and core operating income come from the company's full-year results release; capex and capital retention are conservative assumptions because the company did not separately and fully disclose maintenance capex in the snippets reviewed here, and insurers must retain part of their capital to support ratings, reserves, and premium growth.
This estimate is more conservative than directly using 2025 core operating EPS of $24.79 or the approximate TTM core operating EPS of about $27.93. The reason is simple: not all accounting earnings are money that can be taken out today. Under this framework, CB's current share price does not correspond to cheap owner earnings of just over 11x, but more like a conservative owner-earnings multiple of around 16x. That is why my attitude toward the price is not as enthusiastic as my attitude toward the business quality.
Valuation and Margin of Safety
Intrinsic Value Estimate
First, the framework: I separate facts, assumptions, inferences, and opinions.
| Category | Content |
|---|---|
| Facts | Current share price about $328.25; 2025 core operating income of $9.954 billion; year-end 2025 BVPS of $188.59; Q1 2026 shareholders' equity of $73.788 billion and current shares outstanding of about 387.86 million; 2025 core ROE of 13.7%; 2025 combined ratio of 85.7%. |
| Assumptions | Long-term owner earnings per share growth of 3%-5% for the insurance business; discount rate of 9%-10%; terminal growth rate of 2.5%-3.5%; reasonable P/B midpoint of 1.6x-1.8x. |
| Inferences | Conservative, fair, and optimistic intrinsic value ranges. |
| Opinion | The current price does not provide enough margin of safety. |
Note: the facts come from company results releases, the quarterly report, and market prices.
Method one: Owner Earnings DCF. Starting with conservative owner earnings per share of $19.5-$20.5, I use three valuation cases: the conservative case assumes 3% compound growth over the next 10 years, a 10% discount rate, and 2.5% terminal growth; the neutral case assumes 4% growth, a 9.5% discount rate, and 3% terminal growth; the optimistic case assumes 5% growth, a 9% discount rate, and 3.5% terminal growth. Under this framework, valuation roughly falls into: conservative $260-$285, neutral $330-$360, optimistic $430-$470. The most fragile assumption here is not the growth rate, but "whether record-level underwriting profitability can be sustained." If industry pricing weakens and reserves deteriorate, the starting point needs to be revised downward.
Method two: relative valuation. For insurers, EV/EBITDA and P/FCF, commonly used for ordinary industrial companies, have limited decision value; I pay more attention to P/B, P/TBV, ROE, and combined ratio. Based on the recent share price and the latest available book data: Chubb is at about 1.7x P/B; Travelers is at about 2.0x P/B; Progressive is at about 3.6x P/B; Arch Capital is at about 1.4x P/B. Chubb sits between Arch and Travelers/Progressive, indicating that the market gives it a quality premium, but not the near "god-tier pricing power" valuation of Progressive. This position is not unreasonable, but it is not cheap either.
Method three: asset and liquidation value. At year-end 2025, the company had BVPS of $188.59 and TBVPS of $126.22; the current share price implies the market is paying about 1.74x book value and about 2.6x tangible book value. For an insurer with mid-teens ROE, very strong ratings, and long-term underwriting profitability, this premium is reasonable; but it also means the market has already paid for a large amount of franchise value in advance. The asset method is more suitable for setting the lower bound: I think $230-$265 can be viewed as a "quality asset value range," but it is not enough to explain the company's full value as a going concern.
Putting the three methods together, I arrive at the following ranges:
| Range | Value Judgment |
|---|---|
| Conservative intrinsic value range | $255-$285/share |
| Fair intrinsic value range | $300-$345/share |
| Optimistic intrinsic value range | $380-$430/share |
| Ideal buy price range | $260-$290/share |
| Acceptable holding price range | $290-$340/share |
| Clearly overvalued price range | Above $380 |
At the current price of about $328.25, the stock trades at a premium to conservative intrinsic value, near the midpoint of fair intrinsic value, and still at a discount to optimistic intrinsic value. For conservative value investors, the real point is: I do not buy stocks for the optimistic case. Therefore, I judge that the current price offers no obvious margin of safety.
Margin of Safety Judgment
I think the most fragile valuation assumption for this stock today is that the current excellent underwriting profitability can continue for a fairly long time. The full-year 2025 P&C combined ratio was 85.7%, and Q1 2026 was 84.0%, which is an exceptionally strong result in insurance. If future industry competition intensifies, pricing weakens, loss costs rise, or casualty reserves no longer release favorably, then the "seemingly cheap P/E of just over 11x" can quickly become "a not-cheap valuation on cyclical peak earnings."
So, good company but bad price is not an exaggerated description for Chubb; the more precise description is: good company, acceptable price, but not cheap enough to make me excited. For capital with a horizon longer than 10 years, if you have no better opportunities, it can be viewed as a "quality position candidate"; but for conservative new money, I would rather wait for an opportunity closer to the $260-$290 range before discussing a clearer buy-side margin of safety.
Risks, Comparisons, and Final Judgment
Risks, Bear Case, and Disconfirming Conditions
The most important risk is not short-term share-price volatility, but permanent capital loss. For Chubb, the main risks worth watching are: misjudgment of casualty reserves, frequent catastrophes combined with rising reinsurance costs, a weakening industry pricing cycle, investment-portfolio and FX volatility weighing on book value, and continued repurchases at high prices lowering capital returns. Among these risks, the first two affect earnings, the latter two affect valuation, and most of them will not "happen gently" within a single quarter.
The strongest bear case is roughly this: what you are seeing now is a Chubb benefiting simultaneously from a favorable underwriting cycle, investment-income cycle, and reserve-release cycle. In 2025, the company recorded its best full-year combined ratio in history, and Q1 2026 looked especially strong because the California wildfire comparison base in Q1 2025 was extremely high; once the pricing environment softens, prior-period reserve releases decline, and catastrophe losses revert to the mean or worse, earnings will normalize and the market's franchise premium will compress. Net catastrophe losses were $1.641 billion in Q1 2025 and $500 million in Q1 2026, and that year-over-year improvement itself reminds us: do not treat a low-cat quarter as the new normal.
What facts would overturn my neutral-to-cautious judgment? I would watch several things closely: first, if the current accident year combined ratio excluding catastrophes deteriorates materially for consecutive periods; second, if prior-period reserve development turns from consistently favorable to consistently adverse; third, a ratings downgrade; fourth, a clear rise in the financial debt-to-adjusted capitalization ratio; fifth, book value per share/tangible book value per share stops growing while the company continues large repurchases. These are not noise; they are the skeleton of the investment thesis. The company's ratings remain strong, and debt-to-adjusted capitalization is only 18.3%, which is why I have not assigned an "Avoid" rating.
The largest permanent capital loss scenario can be imagined this way: if the market reprices Chubb from about 1.7x book value today to 1.2x book value, based on current book value of about $190/share, the share price could return to around $228, a decline of about 30%; if book value impairment and multiple compression occur simultaneously, such as book value falling to $170/share and the market assigning only 1.1x, the share price could approach $187, equivalent to a drop of more than 40% from the current price. This is not my most likely scenario, but it is the "bad year for insurance stocks" stress test I must be willing to accept in advance.
Comparison With Other Opportunities
Compared with peers, Chubb's advantages are that it is more balanced, more global, and more like an "insurance complex"; compared with Travelers, it is more international and more diversified, but at current prices Travelers' book multiple and earnings multiple are somewhat cheaper; compared with Progressive, Chubb's valuation is clearly cheaper on book value, but its pricing power and personal-lines machine efficiency are also less extreme than Progressive's; compared with Arch, Chubb has a more complete franchise and stronger ratings and retail/commercial channels, but its book multiple is also higher. In simple terms: Chubb is high quality, but it is not the cheapest among peers.
Compared with the index, I do not think buying Chubb now is clearly superior to buying the S&P 500. Chubb's business certainty may be higher than that of many index constituents, but expected returns around the current price may not be significantly higher; compared with risk-free returns, the U.S. 10-year Treasury yield is about 4.56%, and starting from the current Chubb price, I would assign only 4%-6% expected annualized return in the conservative case, 7%-9% in the neutral case, and 10%-12% in the optimistic case. It can certainly beat Treasuries, but the risk compensation is not large enough to make me buy today.
If I could hold only 5 assets, my answer would be: as a business, Chubb qualifies; as a new position at today's price, it does not automatically enter my top five for now. This is the result of separating my judgment on "business quality" from my judgment on "purchase price."
Investment Checklist
| Checklist Question | Conclusion |
|---|---|
| Can I understand this business? | Pass |
| Does it have stable long-term demand? | Pass |
| Does it have a durable moat? | Pass |
| Does it have pricing power? | Pass, but not unlimited |
| Can it generate stable free cash flow? | Pass, but must be understood through an insurance lens |
| Are its returns on capital excellent? | Pass |
| Is management trustworthy? | Pass |
| Is capital allocation rational? | Pass |
| Is the balance sheet sound? | Pass |
| Is valuation below intrinsic value? | Uncertain / leaning no |
| Is the margin of safety sufficient? | Fail |
| Would I feel comfortable holding it long term? | Pass as a business; not fully pass as a new position at today's price |
| What key facts would make me sell? | Reserve deterioration, ratings downgrade, loss of underwriting discipline, leverage increase |
| Am I only tempted to buy because the share price has risen or because of sentiment? | Should avoid |
Final Investment Conclusion
【Final Rating】 Watch
【One-Sentence Investment Thesis】 Chubb is a high-quality insurer worth studying and owning for the long term, but the current price is closer to a "fair business price" than a "significantly undervalued price."
【Core Bull Case】
Underwriting discipline is very strong, with full-year P&C combined ratios consistently between 87.6% and 85.7% from 2022 to 2025, and 2025 setting a company record.
The global, multi-engine business structure is more balanced: commercial insurance, personal insurance, reinsurance, and life insurance all contribute profit, and the company operates in 54 countries and territories.
Capital strength and ratings are excellent: Q1 2026 shareholders' equity of $73.788 billion, financial debt-to-adjusted capitalization of 18.3%, and main insurance-entity ratings in the Aa2/AA/A++ range.
Management is notably long-term oriented, with incentives tied to growth in tangible book value per share and combined ratio, plus governance constraints such as share-ownership and anti-hedging rules.
Historical capital allocation has generally been better than most peers, with consistent dividend growth and ongoing repurchases.
【Core Bear Case】
The current price has no obvious margin of safety, sitting closer to the middle of the fair range than the undervalued range.
The current earnings environment is favorable: the full-year 2025 and Q1 2026 combined ratios are both at very strong levels, creating mean-reversion risk.
Insurance earnings are highly sensitive to catastrophes and reserves, and the difference between Q1 2025 and Q1 2026 catastrophe losses shows that quarterly profit can be very volatile.
The industry pricing cycle may soften, and both NAIC and Swiss Re have warned that higher underwriting capacity and renewed competition could compress future profitability.
Repurchases at the current price do not necessarily mean the stock is cheap; for new shareholders, management "continuing to buy" does not automatically mean "high odds."
【Key Assumptions】
The company can keep its long-term combined ratio around 87% or better.
Commercial and personal-lines pricing discipline does not yield to scale.
Casualty reserves do not show consecutive material adverse development.
Financial strength ratings remain at current high levels.
Overseas consumer/life insurance growth continues to add diversification rather than uncontrolled complexity.
【Fair Buy Price】 $260-$290/share. The basis is a conservative Owner Earnings DCF, a conservative valuation of about 1.4x-1.5x book value, and a discount requirement for insurance earnings mean reversion.
【Target Holding Period】 More than 10 years. This is not a stock for betting on quarterly volatility, but one suitable to hold as a business at the right price.
【Expected Annualized Return】
Conservative case: 4%-6%
Neutral case: 7%-9%
Optimistic case: 10%-12%
These return assumptions are based on sustained business quality, no significant expansion of the valuation midpoint, and continued contribution from dividends and repurchases to per-share value growth. At the current price, returns are not poor, but they are not at the "must buy now" level.
【Maximum Loss Risk】 About 30%-45%. The worst-case scenario is reserve deterioration, frequent catastrophes, industry softening, pressure on book value, and valuation falling back toward roughly 1.1x-1.2x book value.
【Tracking Metrics】
P&C combined ratio
Current accident year combined ratio excluding catastrophes
Prior-period reserve development
Core ROE / core ROTE
Book value per share and tangible book value per share
Growth quality of life insurance and international consumer businesses
Financial debt-to-adjusted capitalization ratio
Credit quality of the fixed-income portfolio
Net catastrophe losses and reinsurance costs
Relationship between repurchase price and intrinsic value
【Signals Triggering Reassessment】
Combined ratio rises materially for several consecutive quarters
Prior-period reserves turn from favorable to persistently adverse
Ratings downgrade
Financial leverage keeps rising
Management clearly starts prioritizing scale over returns
Repurchases and acquisitions are significantly increased at high valuations
Overseas consumer/life insurance expansion leads to deteriorating returns rather than diversification benefits
【Final Recommendation】 Calmly stated, Chubb deserves respect, but the current price does not deserve chasing. If you already own it at a lower cost, I would lean toward continuing to hold, with the focus on underwriting discipline and reserve quality; if you are a conservative long-term investor preparing to build a new position, I would rather put it on a high-priority watchlist and wait for a price with a larger margin of safety, instead of ignoring purchase return simply to own a good company. True value investing is not just about finding good businesses; it is about committing more capital when a good business and a good price appear at the same time.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free